BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  How COVID-19 is Still Changing the Biopharma Industry, Now and in the Future

  The development of COVID-19 vaccines, which took only months from the initial gene sequencing to the time shots were in arms, was the biggest story of 2020 alongside the pandemic itself.

  August 25, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  Pneumococcal Vaccine Candidate Vaxneuvance for Infants Meets Key Endpoints in Phase III Trial

  Merck has announced its vaxneuvance for pneumococcal disease in infants and has met key safety, tolerability, and immunogenicity endpoints in the first 30 days.

  August 25, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Cardior Raises $76 Million to Advance Heart Failure Treatment

  Funds will be used to advance the clinical development of Cardior’s lead program, CDR132L, an oligonucleotide-based ncRNA inhibitor targeting micro-RNA-132.

  August 25, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  Rubix Announces New Facilities Expected to Create 300 High-Paying Jobs

  Rubix Life Sciences has launched a dedicated therapeutics division to focus on infectious and neurodegenerative diseases.

  August 25, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Policy

  Additional Studies Point to Waning Immunity from Vaccines

  Studies are also continuing on the value and efficacy of booster shots, particularly against the Delta variant. Read on for more information.

  August 25, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  UPDATED: Cassava Sciences Responds to Allegations that Data is Manipulated and “Defies Logic”

  The petition was posted on Monday by shareholder rights law firm Labaton Sucharow.

  August 25, 2021

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Business

  Let’s Get to Know Yoav Kimchy, Founder and Chief Technology Officer of Check-Cap

  BioSpace recently spoke with Yoav Kimchy, founder and chief technology officer of Check-Cap, a company developing the C-Scan® system to detect precancerous polyps.

  August 25, 2021

   · 

  5 min read

   · 

  Gina Hagler
• 

  Job Trends

  MassBio Industry Snapshot Predicts 40,000 New Biopharma Jobs Over the Next 10 Years

  The Bay State biopharma industry continues to boom, even during the height of a global pandemic that has caused an economic downturn in other business sectors.

  August 25, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Brii Bio’s Monoclonal Antibody Combo Shows Promise in COVID, Interim Analysis Shows

  Early data from a Phase III study for COVID-19 shows significant promise with its combo therapy reduced death and hospitalization in trial patients at high risk of progression by 78%.

  August 25, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Alzheimer’s Biomarker Summit: Honing in on Biomarkers for Disease Detection

  The Annual Biomarkers for Alzheimer’s Disease Summit is running from August 25-26. Here’s a look at some of the top stories from day one.

  August 25, 2021

   · 

  2 min read

   · 

  Mark Terry